The proportion of IL-17-, IL-21-, IL-6-, and IL-23-positive cells in the RHD group was found to be dramatically higher compared to the degenerative valve disease control group, highlighting the critical role of these cytokines in RHD pathology. This evidence concerns the gene IL6 and rheumatic heart disease.